لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Klareskog, L, Moreland, LW, Cohen, SB, Baumgartner, SW, Tindall, EA, Kalden, JR, Whitmore, JB, Tsuji, WH

المصدر: ANNALS OF THE RHEUMATIC DISEASES. 64:410-410

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:12539611

المؤلفون: Cheng LE; Amgen, Thousand Oaks, California., Amoura Z; Hôpital Pitié-Salpêtrière, Paris, France., Cheah B; International Medical University, Kuala Lumpur, Malaysia., Hiepe F; Charité Universitätsmedizin Berlin, Berlin, Germany., Sullivan BA; Amgen, Thousand Oaks, California., Zhou L; Amgen, Thousand Oaks, California., Arnold GE; Amgen, Thousand Oaks, California., Tsuji WH; Amgen, Thousand Oaks, California., Merrill JT; Oklahoma Medical Research Foundation, Oklahoma City., Chung JB; Amgen, Thousand Oaks, California.

المصدر: Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2018 Jul; Vol. 70 (7), pp. 1071-1076. Date of Electronic Publication: 2018 May 25.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 101623795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2326-5205 (Electronic) Linking ISSN: 23265191 NLM ISO Abbreviation: Arthritis Rheumatol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Arthritis/*drug therapy , Inducible T-Cell Co-Stimulator Ligand/*immunology , Lupus Erythematosus, Systemic/*drug therapy, Adolescent ; Adrenal Cortex Hormones/therapeutic use ; Adult ; Aged ; Antibodies, Monoclonal, Humanized/immunology ; Arthritis/immunology ; Arthritis/pathology ; Double-Blind Method ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Joints/drug effects ; Joints/pathology ; Lupus Erythematosus, Systemic/immunology ; Lupus Erythematosus, Systemic/pathology ; Male ; Middle Aged ; Severity of Illness Index ; Treatment Outcome ; Young Adult

المؤلفون: Pan WJ; Pharmacokinetics and Drug Metabolism Amgen Inc. Seattle Washington., Li H; Pharmacokinetics and Drug Metabolism Amgen Inc. Seattle Washington., Xiao JJ; Pharmacokinetics and Drug Metabolism Amgen Inc. Thousand Oaks Washington., Horner MJ; Comparative Biology and Safety Sciences Amgen Inc. Thousand Oaks California., Lebrec HN; Comparative Biology and Safety Sciences Amgen Inc. Seattle Washington., Butz EA; Inflammation Discovery Research Amgen Inc. Seattle Washington., Kaliyaperumal A; Medical Sciences Amgen Inc. Thousand Oaks California., Cheah TC; Pharmacokinetics and Drug Metabolism Amgen Inc. Thousand Oaks Washington., Ortiz RC; Pharmacokinetics and Drug Metabolism Amgen Inc. Thousand Oaks Washington., Prokop SP; Pharmacokinetics and Drug Metabolism Amgen Inc. Seattle Washington., Buntich SA; Comparative Biology and Safety Sciences Amgen Inc. Thousand Oaks California., Boren BM; Comparative Biology and Safety Sciences Amgen Inc. Seattle Washington., Wolford ST; Covance Laboratories Inc. Madison Wisconsin., Tsuji WH; Medical Sciences Amgen Inc. Seattle Washington., Wienkers LC; Pharmacokinetics and Drug Metabolism Amgen Inc. Seattle Washington., Köck K; Pharmacokinetics and Drug Metabolism Amgen Inc. Seattle Washington.

المصدر: Pharmacology research & perspectives [Pharmacol Res Perspect] 2016 Jan 11; Vol. 3 (6), pp. e00199. Date of Electronic Publication: 2016 Jan 11 (Print Publication: 2015).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons Ltd, British Pharmacological Society and American Society for Pharmacology and Experimental Therapeutics Country of Publication: United States NLM ID: 101626369 Publication Model: eCollection Cited Medium: Print ISSN: 2052-1707 (Print) Linking ISSN: 20521707 NLM ISO Abbreviation: Pharmacol Res Perspect Subsets: PubMed not MEDLINE

المؤلفون: Gow JM; Amgen, Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA. jasonmg8@yahoo.com., Tsuji WH; Amgen, Inc, 1201 Amgen Court West, Seattle, WA, 98119, USA. tsujiw@amgen.com., Williams GJ; Amgen, Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA. gary.j.williams@questdiagnostics.com.; Quest Diagnostics, Inc, 1311 Calle Batido, San Clemente, CA, 92673, USA. gary.j.williams@questdiagnostics.com., Mytych D; Amgen, Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA. dmytych@amgen.com., Sciberras D; Amgen Limited, 240 Cambridge Science Park, Milton Road, Cambridge, CB4 0WD, UK. david.sciberras@ucb.com., Searle SL; PRA Health Sciences, 3838 South 700 East, Salt Lake City, UT, 84106, USA. searleshawn@prahs.com., Mant T; Quintiles Drug Research Unit at Guy's Hospital, 6 Newcomen Street, London, SE1 1YR, UK. tim.mant@quintiles.com., Gibbs JP; Amgen, Inc, One Amgen Center Drive, Thousand Oaks, CA, 91320, USA. gibbsj@amgen.com.

المصدر: Arthritis research & therapy [Arthritis Res Ther] 2015 Oct 08; Vol. 17, pp. 282. Date of Electronic Publication: 2015 Oct 08.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal/*administration & dosage , Antibodies, Monoclonal/*adverse effects , Antibodies, Monoclonal/*pharmacokinetics , Nerve Growth Factor/*antagonists & inhibitors , Osteoarthritis, Knee/*drug therapy, Adult ; Dose-Response Relationship, Drug ; Double-Blind Method ; Female ; Healthy Volunteers ; Humans ; Male

المؤلفون: Köck K; Pharmacokinetics and Drug Metabolism, Amgen Inc., Seattle, WA, USA., Pan WJ, Gow JM, Horner MJ, Gibbs JP, Colbert A, Goletz TJ, Newhall KJ, Rees WA, Sun Y, Zhang Y, O'Neill JC, Umble-Romero AN, Prokop SP, Krill CD, Som L, Buntich SA, Trimble MW, Tsuji WH, Towne JE

المصدر: British journal of pharmacology [Br J Pharmacol] 2015 Jan; Vol. 172 (1), pp. 159-72. Date of Electronic Publication: 2014 Dec 15.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5381 (Electronic) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal*/blood , Antibodies, Monoclonal*/pharmacokinetics , Antibodies, Monoclonal*/pharmacology , Antibodies, Monoclonal*/toxicity, Interleukin-23/*antagonists & inhibitors, Animals ; Antibodies, Monoclonal, Humanized ; Female ; Humans ; Interferon-gamma/metabolism ; Interleukin-23/immunology ; Interleukin-23/metabolism ; Killer Cells, Natural/drug effects ; Killer Cells, Natural/metabolism ; Macaca fascicularis ; Male ; Toxicity Tests

المؤلفون: Davis JC Jr; University of California, San Francisco, 533 Parnassus Avenue, Box 0633, Room U 386, San Francisco, CA 94143-0633 USA. jdavis@medicine.ucsf.edu, van der Heijde DM, Braun J, Dougados M, Clegg DO, Kivitz AJ, Fleischmann RM, Inman RD, Ni L, Lin SL, Tsuji WH

المصدر: Annals of the rheumatic diseases [Ann Rheum Dis] 2008 Mar; Vol. 67 (3), pp. 346-52. Date of Electronic Publication: 2007 Oct 29.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE

مواضيع طبية MeSH: Antirheumatic Agents/*therapeutic use , Immunoglobulin G/*therapeutic use , Receptors, Tumor Necrosis Factor/*therapeutic use , Spondylitis, Ankylosing/*drug therapy, Adult ; Antirheumatic Agents/adverse effects ; Double-Blind Method ; Etanercept ; Female ; Follow-Up Studies ; Humans ; Immunoglobulin G/adverse effects ; Male ; Middle Aged ; Severity of Illness Index ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors